When was Lilly founded?

Lilly was founded in 1876 and raised its 1st funding round 131 years after it was founded.

Where is Lilly located?

Lilly is headquartered in Indianapolis, United States. It is registered at PLOT NO-92SECTOR 32 GURGAON, HARYANA, Haryana, India, 122001.

How many employees does Lilly have?

As of Jul 31, 2026, the latest employee count at Lilly is 57452.

Is Lilly a funded company?

Lilly is a funded company, having raised an undisclosed amount across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 28, 2007.

When was the latest funding round of Lilly?

Lilly's latest funding was a $***** Post IPO round on 2020, with participation from 1 investor.

What is the annual revenue of Lilly?

Annual revenue of Lilly is more than $1B as on Dec 31, 2025

Where does Lilly rank among its competitors?

Lilly ranks 4th amongst 1824 active competitors, of which 96 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Lilly?

Lilly's top competitors include AbbVie, Amgen and Gilead. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Lilly - 2026 Company Profile, Team, Funding, Competitors & Financials

Lilly is a public company based in Indianapolis (United States), founded in 1876 by Eli Lilly. It operates as a Developer of traditional pharmaceutical medicines. Lilly has raised an undisclosed amount in funding. The company has 1824 active competitors, including 96 funded and 201 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.

Company Details

Developer of traditional pharmaceutical medicines. It produces medicines in oncology, cardiovascular, diabetes, critical care, neuroscience, men’s health, and musculoskeletal fields. In 2022, the company recorded annual revenues of $28.54B and a net profit of $6.24B.

Website: lilly.com
Social
Email ID: *****@lilly.com
Phone Number: +1 **********
Registered Address: PLOT NO-92SECTOR 32 GURGAON, HARYANA, Haryana, India, 122001

Key Metrics

Founded Year

1876

Location

Indianapolis, United States

Stage

Public

Latest Funding Round

Post IPO, 2020, $*****

Investors

Alcor Fund & 12 more

Ranked

4^th among 1824 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

57,452 as on Jul 31, 2026

Investment & Acquisitions

Leal Therapeutics & 178 more

Similar Companies

AbbVie & 1851 more

Exit Details

Public

View Lilly's full profile

Lilly is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ELI LILLY SERVICES INDIA PRIVATE LIMITED CIN: U72200KA2015FTC082300 , India, Active	Aug 17, 2015	₹1,000+ Cr (As on Mar 31, 2025)	2872 (As on Jan 31, 2024)
ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED CIN: U24239HR1993PTC034844 , India, Active	Mar 18, 1993	₹1,000+ Cr (As on Mar 31, 2025)	-
LILLY HQ ApS CIN: 41281782 , Denmark, Active	Apr 02, 2020	-	-
LILLY A/S CIN: 29606668 , Denmark, Active	May 29, 2006	-	-
LILLY ELI & CO CIN: 59478 , United States, Active		$1B+ (As on Dec 31, 2025)	39000 (As on Dec 31, 2022)	-

Lilly got listed on Jan 06, 1978.

Click here to take a look at Lilly's IPO in detail

Lilly has raised funding over 9 rounds. Its first funding round was on Jun 28, 2007. Its latest funding round was a Post IPO round on 2020 for $*****. 1 investor participated in its latest round. Lilly has 13 institutional investors.

Here is the list of recent funding rounds of Lilly:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2020	7157	Post IPO	6025	1349	6968	4348
Mar 03, 2019	7303295	Conventional Debt	1155300	2275291	9997048	1934111
Aug 01, 2018	5166366	Grant (prize money)	4308400	7096722	8435930	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Lilly's funding rounds and investors

The founders of Lilly is Eli Lilly.

Here are the details of Lilly's key team members:

Eli Lilly: Founder of Lilly. They are also an angel investor in 15 startups.

View details of Lilly's Founder profiles and Board Members

Lilly's employee count trend

Lilly has 57,452 employees as of Jul 26. Here is Lilly's employee count trend over the years:

Uncover Lilly's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lilly include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Lilly, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	81/100
2nd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	81/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	Jindal ventures, Seaside Private Capital ... & 17 others	80/100
4th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
5th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
6th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	73/100
7th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
8th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	70/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, Triodos Investment Management ... & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	69/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Lilly's competitors? Click here to see the top ones

Lilly has made 140 investments in companies including Leal Therapeutics and InduPro. Lilly has also acquired 39 companies including AtaiBeckley and 4E Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Aug 17, 2026	Investments	Leal Therapeutics	2021	New York City (United States)
Aug 12, 2026	Investments	InduPro	2022	Seattle (United States)
Aug 12, 2026	Investments	Amplifica	2008	San Diego (United States)